Open Access
CC BY 4.0 · Arq Neuropsiquiatr 2025; 83(07): s00451809660
DOI: 10.1055/s-0045-1809660
Point of View

High-intensity focused ultrasound (HIFU) versus deep brain stimulation (DBS) for refractory tremor: team HIFU

1   Universidade de São Paulo, Faculdade de Medicina, Departamento de Neurologia, Centro de Distúrbios do Movimento, São Paulo SP, Brazil.
2   Hospital Israelita Albert Einstein, Departamento de Neurologia, São Paulo SP, Brazil.
,
3   Hospital Israelita Albert Einstein, Departamento de Imagem, São Paulo SP, Brazil.
4   Universidade de São Paulo, Faculdade de Medicina, Hospital das Clínicas, Instituto de Radiologia, Seção de Neurorradiologia, São Paulo SP, Brazil.
› Institutsangaben
Preview

Abstract

High-intensity focused ultrasound (HIFU) has emerged as a minimally invasive and incision-free alternative for managing tremors associated with essential tremor (ET) and Parkinson's disease (PD). Approved by the United States Food and Drug Administration (FDA) for unilateral and staged bilateral thalamotomy, HIFU also addresses cardinal PD symptoms such as rigidity and bradykinesia through pallidotomy. Tremor improvement rates range from 50 to 75% for ET and 60 to 90% for tremor-dominant PD, with long-term efficacy sustained up to 5 years posttreatment, including 73% tremor improvement in a recent controlled multicenter study. Unlike deep brain stimulation (DBS), HIFU eliminates hardware-related complications, such as infections and intracerebral hemorrhage, and minimizes postprocedural maintenance. Adverse events are primarily mild and transient, including temporary paresthesia and imbalance. Real-time magnetic resonance imaging (MRI) guidance enhances targeting precision, enabling patients to resume daily activities within 24 hours. These attributes make HIFU a durable and effective treatment option.

Authors' Contributions

Writing – original draft: KSM; Writing – review & editing: KSM, EFC.


Editor-in-Chief: Hélio A. G. Teive.https://orcid.org/0000-0003-2305-1073


Associate Editor: Carlos Henrique Ferreira Camargo.https://orcid.org/0000-0002-3533-0347


Guest Editor: Rubens Gisbert Cury.https://orcid.org/0000-0001-6305-3327


This article is part of a debate series on Movement Disorders (Essential Tremor Non-Pharmacological Treatment). Check out the other points of view: https://doi.org/10.1055/s-0045-1808087 and https://doi.org/10.1055/s-0045-1808084




Publikationsverlauf

Eingereicht: 27. Januar 2025

Angenommen: 08. März 2025

Artikel online veröffentlicht:
17. Juli 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua Rego Freitas, 175, loja 1, República, São Paulo, SP, CEP 01220-010, Brazil

Bibliographical Record
Karina Silveira Massruhá, Ellison Fernando Cardoso. High-intensity focused ultrasound (HIFU) versus deep brain stimulation (DBS) for refractory tremor: team HIFU. Arq Neuropsiquiatr 2025; 83: s00451809660.
DOI: 10.1055/s-0045-1809660
 
  • References

  • 1 Elias WJ, Huss D, Voss T, Loomba J, Khaled M, Zadicario E. et al. A pilot study of focused ultrasound thalamotomy for essential tremor. N Engl J Med 2013; 369 (07) 640-648 10.1056/NEJMoa1300962
  • 2 Lynn JG, Zwemer RL, Chick AJ. The Biological Application of Focused Ultrasonic Waves. Science 1942; 96 (2483): 119-120 10.1126/science.96.2483.119
  • 3 Fry WJ, Mosberg Jr WH, Barnard JW, Fry FJ. Production of focal destructive lesions in the central nervous system with ultrasound. J Neurosurg 1954; 11 (05) 471-478 10.3171/jns.1954.11.5.0471
  • 4 Elias WJ, Lipsman N, Ondo WG, Ghanouni P, Kim YG, Lee W. et al. A Randomized Trial of Focused Ultrasound Thalamotomy for Essential Tremor. N Engl J Med 2016; 375 (08) 730-739 10.1056/NEJMoa1600159
  • 5 Bond AE, Shah BB, Huss DS, Dallapiazza RF, Warren A, Harrison MB. et al. Safety and Efficacy of Focused Ultrasound Thalamotomy for Patients With Medication-Refractory, Tremor-Dominant Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol 2017; 74 (12) 1412-1418 10.1001/jamaneurol.2017.3098
  • 6 Krishna V, Fishman PS, Eisenberg HM, Kaplitt M, Baltuch G, Chang JW. et al. Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease. N Engl J Med 2023; 388 (08) 683-693 10.1056/NEJMoa2202721
  • 7 Kaplitt MG, Krishna V, Eisenberg HM, Elias WJ, Ghanouni P, Baltuch GH. et al. Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor: An Open-Label Clinical Trial. JAMA Neurol 2024; 81 (09) 939-946 10.1001/jamaneurol.2024.2295
  • 8 Chang JW, Park CK, Lipsman N, Schwartz ML, Ghanouni P, Henderson JM. et al. A prospective trial of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: Results at the 2-year follow-up. Ann Neurol 2018; 83 (01) 107-114 10.1002/ana.25126
  • 9 Abe K, Horisawa S, Yamaguchi T, Hori K, Yamada K, Kondo K. et al. Focused Ultrasound Thalamotomy for Refractory Essential Tremor: A Japanese Multicenter Single-Arm Study. Neurosurgery 2021; 88 (04) 751-757 10.1093/neuros/nyaa536
  • 10 Arcadi A, Aviles-Olmos I, Gonzalez-Quarante LH, Gorospe A, Jiménez-Huete A, de la Corte MM. et al. Magnetic Resonance-Guided Focused Ultrasound (MRgFUS)-Thalamotomy for Essential Tremor: Lesion Location and Clinical Outcomes. Mov Disord 2024; 39 (06) 1015-1025 10.1002/mds.29801
  • 11 Chua MMJ, Blitz SE, Ng PR, Segar DJ, McDannold NJ, White PJ. et al. Focused Ultrasound Thalamotomy for Tremor in Parkinson's Disease: Outcomes in a Large, Prospective Cohort. Mov Disord 2023; 38 (10) 1962-1967 10.1002/mds.29569
  • 12 Armengou-Garcia L, Sanchez-Catasus CA, Aviles-Olmos I, Jiménez-Huete A, Montoya-Murillo G, Gorospe A. et al. Unilateral Magnetic Resonance–Guided Focused Ultrasound Lesion of the Subthalamic Nucleus in Parkinson's Disease: A Prospective Study. Movement Disorders 2024; 39: 2230-2241 10.1002/mds.30020
  • 13 Martínez-Fernández R, Máñez-Miró JU, Rodríguez-Rojas R, Del Álamo M, Shah BB, Hernández-Fernández F. et al. Randomized Trial of Focused Ultrasound Subthalamotomy for Parkinson's Disease. N Engl J Med 2020; 383 (26) 2501-2513 10.1056/NEJMoa2016311
  • 14 Cury RG, Fraix V, Castrioto A, Fernández MAP, Krack P, Chabardes S. et al. Thalamic deep brain stimulation for tremor in Parkinson disease, essential tremor, and dystonia. Neurology 2017; 89 (13) 1416-1423 10.1212/WNL.0000000000004295
  • 15 Giordano M, Caccavella VM, Zaed I, Manzillo LF, Montano N, Olivi A, Polli FM. Comparison between deep brain stimulation and magnetic resonance-guided focused ultrasound in the treatment of essential tremor: a systematic review and pooled analysis of functional outcomes. J Neurol Neurosurg Psychiatry 2020; 91 (12) 1270-1278 10.1136/jnnp-2020-323216
  • 16 Halpern CH, Santini V, Lipsman N, Lozano AM, Schwartz ML, Shah BB. et al. Three-year follow-up of prospective trial of focused ultrasound thalamotomy for essential tremor. Neurology 2019; 93 (24) e2284-e2293 10.1212/WNL.0000000000008561
  • 17 Park YS, Jung NY, Na YC, Chang JW. Four-year follow-up results of magnetic resonance-guided focused ultrasound thalamotomy for essential tremor. Mov Disord 2019; 34 (05) 727-734 10.1002/mds.27637
  • 18 Cosgrove GR, Lipsman N, Lozano AM, Chang JW, Halpern C, Ghanouni P. et al. Magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor: 5-year follow-up results. J Neurosurg 2022; 138 (04) 1028-1033 10.3171/2022.6.JNS212483
  • 19 Khu KJO, Jamora RDG, Aguilar JA, Pascual JSG, Chan KIP, Espenido TMR. et al. Establishing and developing a magnetic resonance-guided focused ultrasound program in a resource-limited setting: the Philippine experience. Neurosurg Rev 2024; 47 (01) 372 10.1007/s10143-024-02624-5
  • 20 Kim M-R, Yun JY, Jeon B, Lim YH, Kim KR, Yang HJ, Paek SH. Patients' reluctance to undergo deep brain stimulation for Parkinson's disease. Parkinsonism Relat Disord 2016; 23: 91-94 10.1016/j.parkreldis.2015.11.010
  • 21 Lu G, Luo L, Liu M, Zheng Z, Zhang B, Chen X. et al. Outcomes and Adverse Effects of Deep Brain Stimulation on the Ventral Intermediate Nucleus in Patients with Essential Tremor. Neural Plast 2020; 2020: 2486065 10.1155/2020/2486065
  • 22 Patel DM, Walker HC, Brooks R, Omar N, Ditty B, Guthrie BL. Adverse events associated with deep brain stimulation for movement disorders: analysis of 510 consecutive cases. Neurosurgery 2015; 11 (1, Suppl 2): 190-199 10.1227/NEU.0000000000000659
  • 23 Baizabal-Carvallo JF, Kagnoff MN, Jimenez-Shahed J, Fekete R, Jankovic J. The safety and efficacy of thalamic deep brain stimulation in essential tremor: 10 years and beyond. J Neurol Neurosurg Psychiatry 2014; 85 (05) 567-572 10.1136/jnnp-2013-304943
  • 24 Krauss JK, Lipsman N, Aziz T, Boutet A, Brown P, Chang JW. et al. Technology of deep brain stimulation: current status and future directions. Nat Rev Neurol 2021; 17 (02) 75-87 10.1038/s41582-020-00426-z
  • 25 França C, Carra RB, Diniz JM, Munhoz RP, Cury RG. Deep brain stimulation in Parkinson's disease: state of the art and future perspectives. Arq Neuropsiquiatr 2022; 80 (5, Suppl 1): 105-115 10.1590/0004-282x-anp-2022-s133
  • 26 Bronstein JM, Tagliati M, Alterman RL, Lozano AM, Volkmann J, Stefani A. et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011; 68 (02) 165 10.1001/archneurol.2010.260
  • 27 Iorio-Morin C, Yamamoto K, Sarica C, Zemmar A, Levesque M, Brisebois S. et al. Bilateral Focused Ultrasound Thalamotomy for Essential Tremor (BEST-FUS Phase 2 Trial). Mov Disord 2021; 36 (11) 2653-2662 10.1002/mds.28716
  • 28 Jameel A, Meiwald A, Bain P, Patel N, Nandi D, Jones B. et al. The cost-effectiveness of unilateral magnetic resonance-guided focused ultrasound in comparison with unilateral deep brain stimulation for the treatment of medically refractory essential tremor in England. Br J Radiol 2022; 95 (1140): 20220137 10.1259/bjr.20220137
  • 29 Meng Y, Pople CB, Kalia SK, Kalia LV, Davidson B, Bigioni L. et al. Cost-effectiveness analysis of MR-guided focused ultrasound thalamotomy for tremor-dominant Parkinson's disease. J Neurosurg 2020; 135 (01) 273-278 10.3171/2020.5.JNS20692
  • 30 Natera-Villalba E, Ruiz-Yanzi M-A, Gasca-Salas C, Matarazzo M, Martínez-Fernández R. MR-guided focused ultrasound in movement disorders and beyond: Lessons learned and new frontiers. Parkinsonism Relat Disord 2024; 122: 106040 10.1016/j.parkreldis.2024.106040
  • 31 Martínez-Fernández R. Focused ultrasound brain therapy is a new tool in the box. Nat Rev Neurol 2024; 20 (08) 443-444 10.1038/s41582-024-00975-7